GlassScriptPhysician profile
Shefali Miglani
NPI 1306973987
$15,176.93
in general payments reported to CMS, 2019-2025
13 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $52.54 · 2021: $632 · 2022: $11K · 2023: $3,554 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,125 · Travel and Lodging: $1,002 · Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,125.00 |
| Travel and Lodging | $1,001.84 |
| Food and Beverage | $590.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $14,624.88 | 2021-2023 | Acuvue |
| Alcon Vision LLC | $156.11 | 2022-2025 | Clareon, Eysuvis |
| Biotissue Holdings INC. | $107.11 | 2022-2023 | |
| Dompe US, INC. | $55.00 | 2025 | Oxervate |
| Carl Zeiss Meditec USA, INC. | $50.97 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $36.57 | 2021 | |
| Sun Pharmaceutical Industries INC. | $32.73 | 2022-2023 | Cequa |
| Kala Pharmaceuticals, INC. | $30.64 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Bausch & Lomb Americas INC. | $16.70 | 2023 | Vyzulta, Lotemax Sm, Prolensa |
| Coopervision INC. | $15.90 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shefali Miglani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.